Biostatisticians draft blueprints for COVID-19 vax trials
Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
February 18, 2021
•
By Sabin Russell
/ Fred Hutch News Service
Dr. Peter Gilbert (left) leads a team of Fred Hutch biostatisticians that pivoted to COVID-19 vaccine trial design. Dr. Holly Janes (right) is a co-principal investigator with Gilbert at the Statistical and Data Management Center for the HIV Vaccine Trials Network.
Dr. Peter Gilbert (top) leads a team of Fred Hutch biostatisticians that pivoted to COVID-19 vaccine trial design. Dr. Holly Janes (below) is a co-principal investigator with Gilbert at the Statistical and Data Management Center for the HIV Vaccine Trials Network.